Drug:
Reaction: DEVICE ISSUE
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25025867 |
US |
82 | 2 |
Drug dose omission by device, Device issue, Device mechanical issue, |
||||
GLATIRAMER ACETATE, |
||||
| 602 | 25025883 |
US |
56 | 2 |
Vision blurred, Weight increased, Blood glucose increased, Device issue, Device defective, |
||||
LIRAGLUTIDE, |
||||
| 603 | 25025976 |
US |
1 | |
Injection site haemorrhage, Device issue, |
||||
ADALIMUMAB, |
||||
| 604 | 25025980 |
IT |
8 | 1 |
Drug dose omission by device, Device occlusion, Device issue, |
||||
SOMATROPIN, |
||||
| 605 | 25026078 |
SE |
61 | 1 |
Altered state of consciousness, Syncope, Device issue, Asthenia, Epilepsy, Feeling abnormal, Balance disorder, Anxiety, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, LEVOTHYROXINE, GABAPENTIN, RASAGILINE, RASAGILINE MESYLATE, |
||||
| 606 | 25026146 |
US |
80 | |
Glycosylated haemoglobin, Skin injury, Needle issue, Device delivery system issue, Incorrect dose administered, Device issue, Accidental exposure to product, |
||||
EXENATIDE, |
||||
| 607 | 25026269 |
US |
32 | 2 |
Device use error, Device power source issue, Device issue, |
||||
TREPROSTINIL, TREPROSTINIL, ERGOCALCIFEROL, APIXABAN, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 608 | 25026326 |
US |
2 | |
Neovascular age-related macular degeneration, Dry age-related macular degeneration, Hypoacusis, Device issue, |
||||
CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, CARBOXYMETHYLCELLULOSE SODIUM, |
||||
| 609 | 25026391 |
US |
15 | 2 |
Infusion site pain, Device issue, Device issue, Device connection issue, Device occlusion, Device occlusion, |
||||
TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHOCARBAMOL, METHOCARBAMOL TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MACITENTAN, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, DIPHENHYDRAMINE HYDROCHLORIDE, OXYGEN, 0XYGEN, CYPROHEPTADINE HYDROCHLORIDE, FAMOTIDINE, LEVALBUTEROL TARTRATE, ONDANSETRON HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 610 | 25026544 |
US |
44 | 1 |
Pruritus, Arthralgia, Device issue, |
||||
RISANKIZUMAB-RZAA, |
||||
| 611 | 25026940 |
US |
66 | 1 |
Blood glucose increased, Device issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 612 | 25027988 |
US |
62 | 2 |
Injection site bruising, Injection site pain, Device issue, |
||||
INSULIN GLARGINE, |
||||
| 613 | 25021222 |
US |
46 | 2 |
Off label use, Accidental underdose, Device issue, No adverse event, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 614 | 25021287 |
US |
1 | |
Incorrect dose administered, Product complaint, Device issue, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 615 | 25021839 |
US |
||
Product contamination physical, Device issue, |
||||
| 616 | 25021963 |
US |
||
Device issue, Product dose omission issue, |
||||
RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, |
||||
| 617 | 25022047 |
CA |
1 | |
Infection, Thrombosis, Diabetic foot, Inappropriate schedule of product administration, Device issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 618 | 25022060 |
US |
1 | |
Product dose omission issue, Device issue, Product dose omission issue, Skin haemorrhage, Peripheral swelling, Drug ineffective, Skin laceration, Device malfunction, Nail injury, |
||||
GUSELKUMAB, |
||||
| 619 | 25022160 |
GB |
1 | |
Lower respiratory tract infection, Chronic obstructive pulmonary disease, Device leakage, Device issue, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 620 | 25022559 |
US |
71 | 2 |
Infusion site pain, Device delivery system issue, Device issue, Device delivery system issue, Device occlusion, Device occlusion, Device use error, Device infusion issue, Device infusion issue, Device use error, |
||||
TREPROSTINIL, TREPROSTINIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ERGOCALCIFEROL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, RIOCIGUAT, SPIRONOLACTONE, OXYGEN, 0XYGEN, MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TORSEMIDE, |
||||
| 621 | 25023569 |
ES |
||
Device issue, |
||||
GOLIMUMAB, |
||||
| 622 | 25024761 |
US |
43 | 2 |
Product dose omission issue, Device defective, Product complaint, Device issue, Needle issue, No adverse event, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, LABETALOL, |
||||
| 623 | 25024770 |
IT |
13 | |
Drug dose omission by device, Device mechanical issue, Device issue, |
||||
SOMATROPIN, |
||||
| 624 | 25024963 |
US |
67 | 1 |
Injection site papule, Injection site haemorrhage, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 625 | 25025076 |
US |
2 | |
Device issue, Drug dose omission by device, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 626 | 25025173 |
KR |
||
Needle issue, Device issue, |
||||
GUSELKUMAB, |
||||
| 627 | 25025345 |
CN |
||
Needle issue, Accidental exposure to product, Product dose omission issue, Device issue, |
||||
GUSELKUMAB, |
||||
| 628 | 25025399 |
US |
9 | 1 |
Device issue, Liquid product physical issue, |
||||
EPINEPHRINE, ADRENALINUM, |
||||
| 629 | 25025416 |
US |
2 | |
Diarrhoea, Abdominal pain, Incorrect dose administered, Device issue, |
||||
| 630 | 25016126 |
US |
2 | |
Product dose omission issue, Device issue, |
||||
| 631 | 25016860 |
TW |
||
Device issue, Device deployment issue, |
||||
GOLIMUMAB, |
||||
| 632 | 25017499 |
US |
2 | |
Injection site pain, Accidental exposure to product, Drug dose omission by device, Device issue, |
||||
SECUKINUMAB, |
||||
| 633 | 25017522 |
US |
1 | |
Injection site haemorrhage, Device issue, |
||||
ADALIMUMAB, |
||||
| 634 | 25018124 |
NL |
65 | 1 |
Orchitis noninfective, Confusional state, Device dislocation, Infected fistula, Subcutaneous abscess, Device issue, Feeling abnormal, Parkinson^s disease, Device leakage, |
||||
| 635 | 25018295 |
US |
2 | |
Device issue, Inappropriate schedule of product administration, |
||||
ALBUTEROL SULFATE, |
||||
| 636 | 25019013 |
US |
6 | 1 |
Ear infection, Device issue, Device use error, Drug dose omission by device, Incorrect dose administered by device, |
||||
SOMATROPIN, SOMATROPIN, SOMATROPIN, |
||||
| 637 | 25019182 |
US |
39 | 2 |
Uterine pain, Device breakage, Device issue, Device expulsion, |
||||
LEVONORGESTREL, |
||||
| 638 | 25019337 |
US |
34 | 1 |
Device issue, Needle issue, Product dose omission issue, Drug ineffective, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 639 | 25019446 |
US |
50 | 2 |
Death, Supraventricular tachycardia, Hypotension, Abdominal pain, Nausea, Dizziness, Device leakage, Device issue, Device leakage, |
||||
TREPROSTINIL, TREPROSTINIL, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, HYDROXYCHLOROQUINE SULFATE, MAGNESIUM HYDROXIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, KETAMINE HYDROCHLORIDE, EPOPROSTENOL, GABAPENTIN, TADALAFIL, CLONIDINE, KETOPROFEN, BUMETANIDE, OXYGEN, 0XYGEN, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, SEVELAMER CARBONATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AMITRIPTYLINE HYDROCHLORIDE, AMBRISENTAN, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
| 640 | 25019537 |
CN |
||
Device issue, Accidental exposure to product, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 641 | 25019645 |
US |
||
Inappropriate schedule of product administration, Discomfort, Device delivery system issue, Device issue, Device leakage, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 642 | 25019913 |
US |
1 | |
Crohn^s disease, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 643 | 25020196 |
CO |
1 | |
Device issue, |
||||
SOMATROPIN, |
||||
| 644 | 25020348 |
US |
||
Product dose omission issue, Device issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 645 | 25020403 |
US |
||
Incorrect dose administered, Device issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 646 | 25020424 |
US |
||
Product dose omission issue, Device issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 647 | 25020427 |
US |
||
Incorrect dose administered, Device issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 648 | 25020569 |
US |
86 | 2 |
Product dose omission issue, Device issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 649 | 25020790 |
CA |
||
Device issue, |
||||
GOLIMUMAB, |
||||
| 650 | 25020839 |
US |
||
Device issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 651 | 25020926 |
US |
76 | 1 |
Device defective, Device issue, Product dose omission issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 652 | 25021024 |
US |
||
Device issue, |
||||
PEGFILGRASTIM, |
||||
| 653 | 25011163 |
US |
1 | |
Device issue, Accidental exposure to product, |
||||
PEGFILGRASTIM, PEGFILGRASTIM, |
||||
| 654 | 25011344 |
US |
1 | |
Device issue, Incorrect dose administered by device, Drug ineffective, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 655 | 25011507 |
US |
30 | 2 |
Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Pregnancy with contraceptive device, Drug ineffective, Device issue, Device material issue, Procedural pain, Anxiety, Emotional disorder, Depression, Dyspareunia, Pain, |
||||
COPPER, |
||||
| 656 | 25011826 |
US |
2 | |
Large intestine polyp, Crohn^s disease, Device issue, |
||||
RISANKIZUMAB-RZAA, |
||||
| 657 | 25011831 |
US |
36 | 2 |
Product dose omission issue, Device issue, Needle issue, Off label use, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 658 | 25011940 |
US |
||
Device issue, |
||||
NITRIC OXIDE, |
||||
| 659 | 25012038 |
US |
38 | 1 |
Device leakage, Device issue, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 660 | 25012084 |
US |
16 | 2 |
Product dose omission issue, Device defective, Device issue, Off label use, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 661 | 25012243 |
US |
2 | |
Device issue, Device malfunction, Incorrect dose administered by device, Wrong technique in product usage process, |
||||
SECUKINUMAB, |
||||
| 662 | 25013691 |
PT |
27 | 2 |
Nerve injury, Complication of device removal, Implant site scar, Implant site scar, Complication of device removal, Device issue, Incorrect product administration duration, |
||||
ETONOGESTREL, |
||||
| 663 | 25014945 |
DO |
12 | 2 |
Device issue, Injection site pain, Crying, |
||||
SOMATROPIN, |
||||
| 664 | 25015318 |
US |
1 | |
Device issue, Product dose omission issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 665 | 25015326 |
FR |
65 | 2 |
Product dose omission issue, Device issue, |
||||
GOLIMUMAB, |
||||
| 666 | 25015332 |
US |
2 | |
Incorrect dose administered, Urticaria, Device difficult to use, Exposure via skin contact, Device defective, Therapeutic response decreased, Visual impairment, Device issue, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 667 | 25006570 |
BR |
36 | 2 |
Ankylosing spondylitis, Product dose omission issue, Device leakage, Device issue, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
| 668 | 25006659 |
US |
56 | 2 |
Device issue, Product dose omission issue, |
||||
GOLIMUMAB, |
||||
| 669 | 25006904 |
US |
85 | 1 |
Injection site urticaria, Injection site pain, Device issue, |
||||
RISANKIZUMAB-RZAA, |
||||
| 670 | 25007057 |
US |
||
Device issue, |
||||
NITRIC OXIDE, |
||||
| 671 | 25007113 |
US |
83 | 2 |
Infusion site infection, Infusion site reaction, Blood potassium decreased, Device issue, Device issue, |
||||
TREPROSTINIL, TREPROSTINIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ACETAMINOPHEN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, IBUPROFEN, OXYGEN, 0XYGEN, ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA ALBA, CALENDULA OFFICINALIS, CHAMOMILLA, CHERRY PLUM, CLEMATIS, COLOCYNTHIS, DULCAMARA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS, MILLEFOLIUM, RHUS TOXICODENDRON, ROCK ROSE, STAR OF BETHLEHEM, SULPHUR, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS,APIS MELLIFICA,ARNICA MONTANA,ARSENICUM ALBUM,BELLADONNA,BELLIS PERENNIS,BRYONIA,CALENDULA OFFICINALIS,CHAMOMILLA,CHERRY PLUM,CLEMATIS VITALBA,COLOCYNTHIS,COMFREY,DULCAMARA LIGNOSA,ECHINACEA ANGUSTIFOLIA,ECHINACEA PURPUREA,EUPATORIUM PERFOLIATUM,FERRUM PHOSPHORICUM,HAMAMELIS VIRGINIANA,HISTAMINUM,HYPERICUM PERFORATUM,IMPATIENS GLANDULIFERA,LEDUM PALUSTRE,MENTHA PIPERITA,MILLEFOLIUM,ORNITHOGALUM UMBELLATUM,PLANTAGO MAJOR,RHUS TOXICODENDRON,ROCKROSE,SULPHUR,VERATRUM ALBUM,VERBASCUM THAPSUS, ALFALFA, ANTIMONIUM CRUDUM, AVENA SATIVA, BERBERIS VULGARIS, CAJUPUTUM, CARBO ANIMALIS, CARBO VEGETABILIS, CHELIDONIUM MAJUS, FEL TAURI, GENTIANA LUTEA, GLYCYRRHIZA GLABRA, ILLICIUM ANISATUM, INDOLUM, KALI CARBONICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, NUX VOMICA, PANCREATINUM, PEPSINUM, RAPHANUS SATIVUS, RHAMNUS PURSHIANA, SKATOLUM, ALLIUM SATIVUM, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CARBO VEGETABILIS, FERRUM IODATUM, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, PHOSPHORICUM ACIDUM, URTICA URENS, AVENA SATIVA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COFFEA CRUDA, ENGLISH OAK, ESCHSCHOLTZIA CALIFORNICA, EUROPEAN HORNBEAM, FICUS CARICA, HUMULUS LUPULUS, IGNATIA AMARA, IMPATIENS GLANDULIFERA, KALI PHOSPHORICUM, KALI SILICATUM, MELISSA OFFICINALIS, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, PYRENEES STAR OF BETHLEHEM, ROCKROSE, SUS SCROFA PARASYMPATHETIC NERVE, PINEAL GLAND, SYMPATHETIC NERVE, VALERIANA OFFICINALIS, VERBENA OFFICINALIS, ZINCUM VALERIANICUM, ADRENALINUM, AETHUSA CYNAPIUM, AGNUS CASTUS, ALFALFA, ARGENTUM NITRICUM, AURUM METALLICUM, AVENA SATIVA, CERATOSTIGMA WILLMOTTIANUM FLOWER, CHERRY PLUM FLOWER, DAMIANA, EUROPEAN ASPEN FLOWER, EUROPEAN HORNBEAM FLOWER, GORSE FLOWER, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, NATRUM MURIATICUM, PASSIFLORA INCARNATA, ROSA CANINA FLOWER, SEPIA, SWEET CHESTNUT FLOWER, THYROIDINUM, WILD MUSTARD FLOWER, BELLADONNA, BLATTA ORIENTALIS, COCCUS CACTI, CORALLIUM RUBRUM, CUPRUM METALLICUM, DROSERA ROTUNDIFOLIA, ECHINACEA ANGUSTIFOLIA, HEDERA HELIX, HYDRASTIS CANADENSIS, IPECACUANHA, KALI NITRICUM, LAC VACCINUM, LOBELIA INFLATA, PASSIFLORA INCARNATA, PERTUSSINUM, SAMBUCUS NIGRA, THYMUS SERPYLLUM, VALERIANA OFFICINALIS, BALSAMUM PERUVIANUM, BORAX, BRYONIA, CALCAREA ACETICA, COCCUS CACTI, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPHORBIUM OFFICINARUM, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, IPECACUANHA, KALI BICHROMICUM, LUFFA OPERCULATA, MERCURIUS CYANATUS, MERCURIUS DULCIS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, PANCREATINUM, SAMBUCUS NIGRA, SANGUINARINUM NITRICUM, SAPONARIA OFFICINALIS, ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS, ACONITUM NAPELLUS, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BELLADONNA, BRYONIA, CHERRY PLUM, CLEMATIS VITALBA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPATORIUM PERFOLIATUM, EUROPEAN OLIVE, FERRUM PHOSPHORICUM, GENTIANA LUTEA, IMPATIENS GLANDULIFERA, INFLUENZA A VIRUS, LACHESIS MUTUS, LUFFA OPERCULATA, ORNITHOGALUM UMBELLATUM, PHOSPHORUS, ROCKROSE, SARCOLACTICUM ACIDUM, VERATRUM ALBUM, YELLOW JASMINE, ARISTOLOCHIA MILHOMENS, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA OFFICINALIS, CARBO VEGETABILIS, CHAMOMILLA, CHERRY PLUM FLOWER, CLEMATIS VITALBA FLOWER, ECHINACEA ANGUSTIFOLIA, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA FLOWER, LACHESIS MUTUS, MILLEFOLIUM, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE FLOWER, RUTA GRAVEOLENS, SARCOLACTICUM ACIDUM, SULPHUR IODATUM, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COLOCYNTHIS, DULCAMARA LIGNOSA, ECHINACEA, EUPATORIUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA, LEDUM PALUSTRE, MENTHA PIPERITA, MILLEFOLIUM, PLANTAGO MAJOR, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE, SULFUR, COMFREY, VERATRUM ALBUM, VERBASCUM THAPSUS, ACETICUM ACIDUM, ADRENALINUM, AMERICAN GINSENG, ARNICA MONTANA, BALSAMUM PERUVIANUM, BOS TAURUS PITUITARUM POSTERIUM, CHERRY PLUM FLOWER, CHININUM ARSENICOSUM, CINCHONA OFFICINALIS, CLEMATIS VITALBA FLOWER, DAMIANA, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE FLOWER, GLYCYRRHIZA GLABRA, IMPATIENS GLANDULIFERA FLOWER, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, PYRENEES STAR OF BETHLEHEM, ROCKROSE FLOWER, SELENIUM METALLICUM, THYROIDINUM, |
||||
| 672 | 25007215 |
US |
65 | 1 |
Delusion, Confusional state, Hallucination, Device issue, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, PRAMIPEXOLE, ISTRADEFYLLINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, AMANTADINE, CARBIDOPA AND LEVODOPA, LEVODOPA, TIZANIDINE, CELECOXIB, |
||||
| 673 | 25007332 |
ES |
87 | 2 |
Overdose, Fear of disease, Freezing phenomenon, Device issue, Device occlusion, Device issue, |
||||
| 674 | 25007653 |
US |
72 | 1 |
Device issue, Product label issue, Product dose omission issue, Device defective, Off label use, Feeling abnormal, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 675 | 25007805 |
US |
1 | |
Dialysis, Device issue, |
||||
PANCRELIPASE, |
||||
| 676 | 25008047 |
US |
31 | 2 |
Device issue, Complication of device removal, |
||||
LEVONORGESTREL, |
||||
| 677 | 25008126 |
US |
||
Device issue, Incorrect dose administered, Product dose omission issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 678 | 25008622 |
US |
65 | 2 |
Fluid retention, Swelling, Paraesthesia, Pain, Chest discomfort, Device use error, Device issue, |
||||
TREPROSTINIL, TREPROSTINIL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MAGNESIUM OXIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MACITENTAN, TADALAFIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ERGOCALCIFEROL, OXYGEN, 0XYGEN, DULAGLUTIDE, DAPAGLIFLOZIN, |
||||
| 679 | 25008757 |
KR |
7 | 1 |
Drug dose omission by device, Device mechanical issue, Device issue, Device use issue, |
||||
SOMATROPIN, |
||||
| 680 | 25009265 |
FI |
||
Device issue, |
||||
DARUNAVIR, DARUNAVIR, |
||||
| 681 | 25009326 |
JP |
||
Device issue, |
||||
GOLIMUMAB, |
||||
| 682 | 25009585 |
ES |
2 | |
Procedural pain, Dyskinesia, Loss of personal independence in daily activities, Flatulence, Device issue, Nervousness, |
||||
| 683 | 25009613 |
US |
2 | |
Device issue, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 684 | 25009644 |
DE |
||
Device issue, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
| 685 | 25009943 |
US |
73 | |
Neuropathy peripheral, Neoplasm malignant, Scar, Nodule, Wrong technique in product usage process, Device issue, Incorrect dose administered by device, Painful respiration, Gastrooesophageal reflux disease, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 686 | 25010080 |
US |
67 | 1 |
Product dose omission issue, Device issue, Accidental exposure to product, Injection site haemorrhage, |
||||
GUSELKUMAB, |
||||
| 687 | 25010212 |
US |
35 | 1 |
Injection site haemorrhage, Device issue, |
||||
RISANKIZUMAB-RZAA, |
||||
| 688 | 25010465 |
GR |
16 | 1 |
Incorrect dose administered by device, Device issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 689 | 25010847 |
US |
82 | 2 |
Breast cancer female, Injection site papule, Device issue, Osteoporosis, Impaired healing, Skin laceration, |
||||
RISANKIZUMAB-RZAA, |
||||
| 690 | 25001839 |
US |
27 | 2 |
Peripheral swelling, Device issue, Fatigue, Oropharyngeal pain, Pain in extremity, Ear infection, Sinusitis, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 691 | 25001969 |
US |
2 | |
Joint swelling, Joint stiffness, Device issue, Ankylosing spondylitis, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 692 | 25002346 |
US |
40 | 2 |
Injection site haemorrhage, Device issue, |
||||
ADALIMUMAB, |
||||
| 693 | 25003147 |
CA |
69 | 1 |
Delirium, Device loosening, Pneumonia, Adverse drug reaction, Catheter site erythema, Catheter site pain, Dermatitis, Device electrical finding, Device issue, Device temperature issue, Electric shock, Frustration tolerance decreased, Hypersomnia, Inflammation, Infusion site abscess, Infusion site reaction, Injection site discharge, Injection site erythema, Intentional medical device removal by patient, Localised infection, Mobility decreased, Nodule, Pain, Papule, Purulence, Gait disturbance, Rash, Somnolence, |
||||
| 694 | 25003302 |
US |
2 | |
Injection site haemorrhage, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 695 | 25003559 |
US |
65 | 2 |
Mental impairment, Urinary tract infection, Device issue, Confusional state, Hallucination, Dehydration, Hallucination, visual, Myocardial infarction, Urinary retention, Agitation, Anxiety, Speech disorder, Diarrhoea, Substance-induced psychotic disorder, Overdose, Off label use, Vomiting, Delusion of reference, Musculoskeletal disorder, Product use issue, |
||||
BACLOFEN, ZICONOTIDE ACETATE, ZICONOTIDE ACETATE, ZICONOTIDE ACETATE, |
||||
| 696 | 25003707 |
US |
65 | 2 |
Injection site haemorrhage, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 697 | 25003733 |
NL |
1 | |
Unresponsive to stimuli, On and off phenomenon, Device issue, Somnolence, Contusion, Device issue, Skin hypertrophy, Diarrhoea, Hyperphagia, Catheter site discharge, Underdose, |
||||
CARBIDOPA AND LEVODOPA, |
||||
| 698 | 25003851 |
US |
18 | 1 |
Device mechanical issue, Device issue, Off label use, |
||||
SOMATROPIN, |
||||
| 699 | 25003887 |
US |
13 | 1 |
Device issue, |
||||
SOMATROPIN, |
||||
| 700 | 25003943 |
US |
2 | |
Product dose omission issue, Device issue, |
||||
GOLIMUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28